Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 1, 1997, Pages 94-100

  Triggiani, Massimo ^a   De Marino, Valeria ^b   Sofia, Matteo ^b   Faraone, Stanislao ^b   Ambrosio, Giuseppe ^b   Carratù, Luigi ^b   Marone, Gianni ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; PHOSPHOLIPASE A2; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

EID: 0030790476     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.1.9608084     Document Type: Article

References (35)

1. Henson, P. M., P. J. Barnes, and S. P. Banks-Schlegel. 1992. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis. 145:726-731.
2. Venable, M. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1993. Platelet-activating factor: a phospholipid autacoid with diverse actions. J. Lipid Res. 34:691-702.
3. Stafforini, D. M., M. E. Elstad, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1990. Human macrophages secrete platelet-activating factor acetylhydrolase. J. Biol. Chem. 265:9682-9687.
4. Triggiani, M., W. C. Hubbard, and F. H. Chilton. 1990. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. J. Immunol. 144:4773-4780.
5. Snyder, F. 1995. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta 1254:231-249.
6. Blank, M. L., T. Lee, V. Fitzgerald, and F. Snyder. 1981. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem. 256:175-178.
7. Farr, R. S., M. L. Wardlow, C. P. Cox, K. E. Meng, and D. E. Greene. 1983. Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. F.A.S.E.B. J. 42:3120-3122.
8. Stafforini, D. M., S. M. Prescott, and T. M. McIntyre. 1987. Human plasma platelet-activating factor acetylhydrolase: association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262:4223-4230.
9. Teaford, H. G., E. N. Charlesworth, D. S. Woodard, and R. N. Pinckard. 1992. Platelet-activating factor (PAF) acetylhydrolase activity in human skin after antigen challenge (abstract). J. Allergy Clin. Immunol. 89:354.
10. Shin, M., F. J. Averill, W. C. Hubbard, F. H. Chilton, F. M. Baroody, M. C. Liu, and R. M. Naclerio. 1994. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am. J. Respir. Crit. Care Med. 149:660-666.
11. 2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. J. Allergy Clin. Immunol. 94:109-119.
12. Triggiani, M., and F. H. Chilton. 1992. Metabolism of platelet-activating factor in the guinea pig heart. J. Mol. Cell. Cardiol. 24:1101-1111.
13. Blank, M. L., M. N. Hall, E. A. Cress, and F. Snyder. 1983. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem. Biophys. Res. Commun. 113:666-671.
14. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1983-1991.
15. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. L. Trong, L. S. Cousens, G. A. Zimmerman, Y. Yamada, T. M. McIntyre, S. M. Prescott, and P. W. Gray. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553.
16. Nakamura, T., Y. Morita, M. Kuriyama, K. Ishihara, K. Ito, and T. Miyamoto. 1987. Platelet-activating factor in late asthmatic response. Int. Arch. Allergy Appl. Immunol. 82:57-61.
17. Stenton, S. C., E. N. Court, W. P. Kingston, P. Goadhy, C. A. Kelly, M. Duddridge, C. Ward, D. J. Hendrick, and E. H. Walters. 1990. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur. Respir. J. 3:408-413.
18. Tsukioka, K., M. Matsuzaki, M. Nakamata, H. Kayahara, and T. Nakagawa. 1996. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J. Investig. Allergol. Clin. Immunol. 6:22-29.
19. National Asthma Education Programme. 1991. Expert Panel on the Management of Asthma. National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. J. Allergy Clin. Immunol. 88:425-534.
20. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. Hance, and B. A. Klogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of lower respiratory tract. N. Engl. J. Med. 310:235-244.
21. National Heart, Lung, and Blood Institute. 1992. Workshop summary and guidelines: investigative use of bronchoscopy, lavage and bronchial biopsy in asthma and other airway disease. J. Allergy Clin. Immunol. 88: 808-814.
22. Lowry, O., N. Rosebrough, A. Farr, and R. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
23. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
24. Snedecor, G. W., and W. G. Cochran. 1980. Statistical Methods, 7th ed. Iowa State University Press, Ames. 175-193.
25. 2 from synovial fluid in rheumatoid arthritis. J. Biochem. 100:1297-1302.
26. 2 from human nasal lavage. Am. J. Respir. Cell Mol. Biol. 11:108-113.
27. Chilton, F. H., F. J. Averill, W. C. Hubbard, A. N. Fonteh, M. Triggiani, and M. C. Liu. 1996. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183:2235-2245.
28. Ambrosio, G., A. Oriente, C. Napoli, G. Palumbo, P. Chiariello, G. Marone, M. Condorelli, M. Chiariello, and M. Triggiani. 1994. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J. Clin. Invest. 93:2408-2416.
29. Calhoun, W. J., H. E. Reed, D. R. Moest, and C. A. Stevens. 1992. Enhanced Superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 145:317-325.
30. Stafforini, D. M., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1991. Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids 26:979-985.
31. Furukawa, M., H. Narahara, K. Yasuda, and J. M. Johnston. 1993. Presence of platelet-activating factor-acetylhydrolase in milk. J. Lipid Res. 34:1603-1609.
32. Poulter, L. W., G. Janossy, C. Power, S. Sreenan, and C. Burke. 1994. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol. Today 15:258-261.
33. Auger, M. J., and J. A. Ross. 1992. The biology of the macrophage. In C. E. Lewis and J. O'D. McGee, editors. The Macrophage. Oxford University Press, IRL Press, Oxford. 1-74.
34. Sedgwick, J. B., K. M. Geiger, and W. W. Busse. 1990. Superoxide generation by hypodense eosinophils from patients with asthma. Am. Rev. Respir. Dis. 142:120-125.
35. Weltzien, H. U. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta 559:259-287.